All news - Aenitis

Past events

Aenitis will be participating in the Congrès France Bioproduction, March 19-20

Emmanuel Vincent, our CEO, will be attending the Congrès France Bioproduction, Tours, France, from 19 to 20 March. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!

Press releases

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced Rare and Complex Cell Sorting in Flow Processes

Access the full Press Release: English Version / French Version ● Pioneering industry collaboration: Bracco and Aenitis join forces to combine expertise in acoustophoresis and functionalised microsystems to revolutionise the sorting of rare and complex cells, driving innovation in biomanufacturing and advanced therapies● Transformative alternative for sorting rare and complex cells: Acoustic microspheres offer a new alternative to magnetic beads, enabling safer, more efficient and scalable solutions● This pioneering technology ensures biocompatibility, improved cell viability and cost-effective processing, making large-scale sorting of rare and complex cells faster and more accessible Paris, France, January 8, 2025 – Aenitis Technologies,

Past events

Aenitis will be participating in the JP Morgan 43rd Annual Healthcare Conference, January 13-16

Emmanuel Vincent, our CEO, will be attending the JP Morgan 43rd Annual Healthcare Conference in San Francisco, CA, USA, from 13 to 16 January. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!

Media coverage

Aenitis has been featured in Biotech et Finances

We are pleased to share that Aenitis has been featured in Biotech et Finances! Our CEO, Emmanuel Vincent, spoke with Guillaume Mollaret about our recent successful fundraising to redefine bioproduction with our unique acoustofluidic technology. During the discussion, Emmanuel Vincent also highlighted the addition of two new members to our Strategic Board and the significant benefits our technology brings to biomanufacturing, including increased yields, reduced costs and improved cell quality. Headline : « AENITIS: DE L’ACOUSTIQUE CELLULAIRE À L’HARMONIQUE DES FONDS » Read the full article on Biotech et Finances: https://biotech-finances.com/?s=aenitis

Media coverage

Aenitis has been featured in Les Echos

We are delighted to announce that Aenitis has been featured in Les Echos following our successful fundraising to redefine bioproduction with our sole-in-class acoustofluidic technology!Thanks to Paul Molga for this enriching interview. Headline: « Aenitis raises 6.5 million euros for its cell sorting machines by levitation »Read the full article on Les Echos: https://www.lesechos.fr/pme-regions/innovateurs/aenitis-attire-65-millions-deuros-pour-ses-machines-de-tri-cellulaire-par-levitation-2124332 Together, we set to redefine biomanufacturing and enhance effective cell processing for research, clinical, and industrial applications.

Press releases

Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology (2024)

Access the full Press Release: English Version / French Version ● Aenitis is set to transform the bioproduction industry by addressing theincreasing need for scalable, cost-effective, and highly precise cell processingtechnologies.● Mitis™, the flagship product of its unique Acoustofluidic Technology, is alreadyused across various applications, from research to clinical and industrial scales,including cell sorting, isolation, concentration, and washing.● Funding round led by the European Innovation Council Fund, Quadrivium I fund(Seventure Partners) and Mifani Invest to support commercial launch and globalexpansion. Paris, France, October 10, 2024-– Aenitis Technologies, a pioneer in acoustic-based cellmanipulation, has successfully closed

Past events

Aenitis will be participating in the Matinale Deeptech on November, 7th

Emmanuel Vincent, our CEO, will participate in the POC Media – Matinale Deeptech: “Les Nouveaux Acteurs des Biothérapies,” organized by the Agence de l’Innovation en Santé and Polepharma at the Paris Santé Cancer Campus on November 7th. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!

Poster ISCT 2023-Low mechanical stress and high throughput concentration of cells with acoustophoresis

Acoustophoresis is an ultrasound based technique to replace most cell sorting and washing devices such as centrifuges. It uses low acoustic radiation forces to make cells migrate to a pressure node. Unlike a centrifuge, Aenitis’ technology works completely in flow and can be part of a more complex fluidic system. It can be used to sort, wash and concentrate all kinds of cells and tissues, with no change in cell viability. Flow rates can range from 0.5 ml/min to 40 ml/min. Previous results have shown that acoustophoresis can be used safely on platelets1.In this study,

Past events

Gentle Technologies Event

We are thrilled to share the resounding success of our recent event, a collaboration that brought together three pioneering startup companies Trince, LiveDrope and Aenitis technologies at the forefront of Gentle Technologies for Cell Processing. This exclusive gathering showcased groundbreaking innovations that are shaping the future of cell processing and advancing the boundaries of biotechnology The success of this event reaffirms our commitment to promoting innovation in biotechnology. As we continue to explore the limitless possibilities of Gentle Technologies for Cell Processing, we look forward to playing a pivotal role in shaping the future of

Past events

ESGCT, Brussels

DATE: Tuesday, October 24, 2023 – Friday, October 27, 2023 LOCATION: Brussels, Belgium The European Society of Gene and Cell Therapy Annual Congress brings together a stellar lineup of over 100 eminent experts who share their most recent research findings and breakthroughs. This distinguished gathering includes Nobel Prize recipients and scientists on the forefront of the field, making ESGCT a platform for exploring the most exciting topics and revolutionary research in the domain of cell and gene therapy. Our sponsorship at ESGCT represents a significant milestone in our journey to redefine the landscape of cell

News